GenomeWeb

Syapse Expands Into Asia With Korean Hospital Deal

Jan 31, 2018

CHICAGO (GenomeWeb) – Syapse, a maker of software to support precision oncology care, has entered the Asian market through a partnership with Seoul National University Hospital. A parallel deal with cloud IT company Megazone will allow the company to reach other potential customers in South Korea, Japan, and Vietnam.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Menu

Syapse Expands Into Asia With Korean Hospital Deal

To read the full story....

Breaking News

Abbott POC Coronavirus Test Snares FDA Emergency Use Authorization

Luminex Receives FDA Emergency Use Authorization for Coronavirus Multiplex Panel

People in the News: Thierry Bernard, Louise Phanstiel, Slava Akmaev, More

10x Genomics Joins Single-Cell Multi-Omics Alliance to Develop Antibody Therapies for Coronavirus

UPDATE: NIH, CDC to Receive Billions in Additional Funding Under Coronavirus Stimulus Bill

In Brief This Week: Broad Institute, CMS, Twist Bioscience, and More

Recent Headlines from
Precision Oncology News

Ovarian Cancer Patients in Netherlands To Get 'Tumor-First' BRCA Testing

Black Diamond Therapeutics Targeting EGFR, HER-Mutated Cancers in Phase I/II Studies

Trovagene Exploring PLK1 Inhibitor in Various Biomarker-Defined Cancer Indications

Follow-up Study Confirms Viability of PD-L1 as Biomarker for Keytruda in Lung Cancer

Genentech Basket Trial Data Supports Genomic Profiling of Salivary Cancer Patients for Precision Treatment

The Scan

Extension Call

All Along the Axon

For the Accelerator

Science Papers Describe New Cas9 Variant, Atlas of Human Metabolism

Featured White Papers

Computational Approaches for Optimized Nanopore Sequencing Workflows

The Role of Single-Cell Functional Biomarkers in Next-Generation Cancer Therapies

Sponsorships